A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
Clinical trial NCT06641648 · RECRUITING
Trial details
- NCT number
- NCT06641648
- Sponsor
- Peking University First Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-12-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.